Nations Financial Group Inc. IA ADV purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 9,409 shares of the company’s stock, valued at approximately $1,988,000.
Several other large investors also recently added to or reduced their stakes in CAH. Aventura Private Wealth LLC purchased a new stake in Cardinal Health during the fourth quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. bought a new position in Cardinal Health during the fourth quarter worth about $26,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health in the fourth quarter worth about $27,000. Jones Financial Companies Lllp raised its position in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Finally, Palladiem LLC bought a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $28,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Cardinal Health Trading Up 0.1%
Shares of Cardinal Health stock opened at $222.08 on Monday. The company’s 50-day moving average price is $204.34 and its 200-day moving average price is $209.28. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The company has a market cap of $52.01 billion, a price-to-earnings ratio of 33.96, a PEG ratio of 1.21 and a beta of 0.52.
Cardinal Health Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. Cardinal Health’s payout ratio is currently 31.19%.
Wall Street Analysts Forecast Growth
CAH has been the subject of several analyst reports. TD Cowen raised their price objective on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a report on Friday, May 1st. Wells Fargo & Company lowered their target price on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Morgan Stanley increased their target price on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Evercore dropped their target price on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Finally, JPMorgan Chase & Co. cut their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $246.93.
About Cardinal Health
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Read More
- Five stocks we like better than Cardinal Health
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
